review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Alan G Wade | |
P2860 | cites work | Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes | Q22299199 |
Tolerance of debility in elderly dependants by supporters at home: its significance for hospital practice | Q51297952 | ||
Prevalence and comorbidity of sleep disorders in general population | Q28257721 | ||
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine | Q28259494 | ||
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. | Q30559869 | ||
Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data | Q30799232 | ||
Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group | Q33873917 | ||
A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France | Q33938358 | ||
Insomnia: epidemiology, characteristics, and consequences | Q33974032 | ||
The effects of trazodone on sleep in patients treated with stimulant antidepressants | Q33975153 | ||
Insomnia: definition, prevalence, etiology, and consequences | Q34006700 | ||
Chronic insomnia and cognitive functioning among older adults | Q34011100 | ||
Place of chronic insomnia in the course of depressive and anxiety disorders | Q34164790 | ||
Critical evaluation of the effect of valerian extract on sleep structure and sleep quality | Q34508145 | ||
Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression | Q34588606 | ||
Usefulness of mindfulness-based cognitive therapy for treating insomnia in patients with anxiety disorders: a pilot study | Q34593172 | ||
Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia | Q35734635 | ||
Clinical and socioeconomic correlates of insomnia | Q35778106 | ||
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation | Q35802609 | ||
Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study | Q35995442 | ||
A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults | Q36253538 | ||
The subjective meaning of sleep quality: a comparison of individuals with and without insomnia | Q36513272 | ||
Recommendations for a standard research assessment of insomnia. | Q36622937 | ||
Self-reported sleep quality predicts poor cognitive performance in healthy older adults | Q37127080 | ||
Insomnia and health-related quality of life | Q37644964 | ||
Searching for the daytime impairments of primary insomnia. | Q37645113 | ||
Societal costs of insomnia | Q37723060 | ||
Attention bias for sleep-related stimuli in primary insomnia and delayed sleep phase syndrome using the dot-probe task. | Q38401209 | ||
Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer | Q39803974 | ||
The relationship between insomnia and patient satisfaction with quality of life in cancer | Q40185544 | ||
The problems of sleep for older women: changes in health outcomes | Q43907721 | ||
Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure | Q44064698 | ||
Quality of sleep and health-related quality of life in haemodialysis patients | Q44197592 | ||
Prevalence of sleep problems and quality of life in an older population. | Q44501612 | ||
Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-term hemodialysis | Q44530671 | ||
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia | Q44679941 | ||
Professional correlates of insomnia | Q44939935 | ||
Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. | Q45022775 | ||
Medical and socio-professional impact of insomnia. | Q45239747 | ||
Restless legs syndrome, insomnia, and quality of life after renal transplantation. | Q46864332 | ||
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects | Q46884215 | ||
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. | Q46944112 | ||
Visual cognitive function: changes associated with chronic insomnia in older adults. | Q47571391 | ||
A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia | Q47975152 | ||
Association between report of insomnia and daytime functioning | Q48387098 | ||
Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors | Q48442471 | ||
Impact of sleep disturbances in inflammatory bowel disease | Q48455215 | ||
Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors | Q48456670 | ||
Psychological and health-related quality of life factors associated with insomnia in a population-based sample | Q48461295 | ||
Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial | Q48465656 | ||
Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. | Q48466083 | ||
Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model | Q48473856 | ||
The burden of chronic insomnia on society | Q48482450 | ||
Insomniac complaints interfere with quality of life but not with absenteeism: respective role of depressive and organic comorbidity | Q48489817 | ||
The economic impact of insomnia in managed care: a clearer picture emerges. | Q48501412 | ||
Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia | Q48506595 | ||
Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study | Q48508312 | ||
Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial | Q48522790 | ||
Self-help treatment for insomnia: a randomized controlled trial | Q48524274 | ||
Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study | Q48534751 | ||
A single-blinded, randomized pilot study evaluating the aroma of Lavandula augustifolia as a treatment for mild insomnia | Q48537167 | ||
Self-reported napping and nocturnal sleep in Taiwanese elderly insomniacs | Q48547184 | ||
Cognitive-behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. | Q48555204 | ||
Insomnia, quality of life and psychopathological features | Q48588092 | ||
Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. | Q48636990 | ||
Cognitive performance and sleep quality in the elderly suffering from chronic insomnia. Relationship between objective and subjective measures | Q48640883 | ||
The relationship between insomnia and health-related quality of life in patients with chronic illness | Q48663819 | ||
Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain | Q48663870 | ||
Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors | Q48684266 | ||
Primary versus secondary insomnia in older adults: subjective sleep and daytime functioning | Q48691209 | ||
Epidemiology of severe insomnia and its consequences in Germany | Q48691385 | ||
SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers | Q48703288 | ||
Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects | Q48705497 | ||
Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group | Q48715305 | ||
Cognitive-behavioral treatment of insomnia secondary to chronic pain | Q48718537 | ||
Public health and insomnia: economic impact. | Q48722217 | ||
Evaluation of severe insomnia in the general population: results of a European multinational survey | Q48732297 | ||
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride | Q48751730 | ||
The direct economic costs of insomnia in the United States for 1995. | Q48755598 | ||
Quality of life in people with insomnia. | Q48755632 | ||
Slow-wave sleep and waking cognitive performance among older adults with and without insomnia complaints | Q48761691 | ||
Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees | Q48762393 | ||
Behavioral treatment of chronic insomnia in psychiatrically ill patients | Q48773151 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | insomnia | Q1869874 |
P304 | page(s) | 1-18 | |
P577 | publication date | 2010-12-20 | |
P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
P1476 | title | The societal costs of insomnia | |
P478 | volume | 7 |
Q36530427 | A quantitative approach to distinguishing older adults with insomnia from good sleeper controls |
Q37486745 | Clinically diagnosed insomnia and risk of all-cause and diagnosis-specific disability pension: a nationwide cohort study |
Q48165233 | Clinically diagnosed insomnia and risk of all-cause and diagnosis-specific sickness absence: a nationwide Swedish prospective cohort study |
Q47669627 | Endoscopic Sinus Surgery Improves Sleep Quality in Chronic Rhinosinusitis: A Systematic Review and Meta-analysis |
Q33607898 | Intensive Sleep Re-Training: From Bench to Bedside |
Q36091969 | Pathological gambling, problem gambling and sleep complaints: an analysis of the National Comorbidity Survey: Replication (NCS-R). |
Q90294885 | Perceived racial discrimination and risk of insomnia among middle-aged and elderly Black women |
Q36430588 | Quality of life in patients suffering from insomnia |
Q26821890 | Sirtuin 3: a molecular pathway linking sleep deprivation to neurological diseases |
Q35890882 | Sleep and gambling severity in a community sample of gamblers |
Q46161178 | Sleep disturbance, personality and the onset of depression and anxiety: prospective cohort study |
Q36831276 | Sleep patterns as predictors for disability pension due to low back diagnoses: a 23-year longitudinal study of Finnish twins |
Q37103429 | Sleep symptoms, race/ethnicity, and socioeconomic position. |
Q47736779 | The Effect of Insomnia on Neuropsychological Functioning in Patients with Comorbid Symptoms of Pain, Fatigue, and Mood Disorders |
Q36536952 | The physical and social environment of sleep in socioeconomically disadvantaged postpartum women |
Q31004694 | Trouble Sleeping Associated With Lower Work Performance and Greater Health Care Costs: Longitudinal Data From Kansas State Employee Wellness Program |
Search more.